Rainbow Children’s Medicare Limited has declared its audited financial results for the quarter and financial year ended March 31, 2026. Along with the financial disclosures, the Board has recommended a final dividend of ₹3.50 per equity share, representing a 35% payout on the face value of ₹10 per share. The company also announced leadership re-appointments and finalized the date for its 28th Annual General Meeting.
Financial Highlights and Dividend
The company successfully concluded its board meeting on May 23, 2026, where the directors reviewed and approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Following these results, the Board recommended a final dividend of ₹3.5 per equity share. This payout is subject to shareholder approval at the upcoming 28th Annual General Meeting, with the dividend expected to be credited or dispatched within 30 days of the meeting.
Annual General Meeting and Record Date
The company has scheduled its 28th Annual General Meeting (AGM) to be held on Wednesday, July 29, 2026. The meeting will be conducted via Video Conferencing/Other Audio-Visual Means (VC/OVAM). Furthermore, the Board has fixed Tuesday, July 21, 2026, as the Record Date for determining eligibility for the final dividend and for participation in the AGM.
Leadership Re-appointments
To ensure long-term strategic continuity, the Board approved the re-appointment of several key leaders for a five-year term effective August 11, 2026, through August 10, 2031, pending member approval:
- Dr. Ramesh Kancharla: Re-appointed as Chairman and Managing Director.
- Dr. Dinesh Kumar Chirla: Re-appointed as Whole Time Director.
Additionally, the company has re-appointed Independent Directors Mr. Santanu Mukherjee (for a second term starting October 2026) and Ms. Sundari R. Pisupati (for a second term starting September 2026). The Board also confirmed the re-appointment of M/s. Lavanya & Associates LLP as Cost Auditors for the 2026-27 financial year.
Source: BSE
